Protalix BioTherapeutics, Inc. (DE) (PLX): Price and Financial Metrics
PLX Price/Volume Stats
| Current price | $1.76 | 52-week high | $1.90 |
| Prev. close | $1.74 | 52-week low | $0.82 |
| Day low | $1.69 | Volume | 344,300 |
| Day high | $1.79 | Avg. volume | 348,197 |
| 50-day MA | $1.43 | Dividend yield | N/A |
| 200-day MA | $1.21 | Market Cap | 129.60M |
PLX Stock Price Chart Interactive Chart >
Protalix BioTherapeutics, Inc. (DE) (PLX) Company Bio
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system in Israel and internationally. The company was founded in 1993 and is based in Carmiel, Israel.
PLX Price Returns
| 1-mo | 6.02% |
| 3-mo | 60.00% |
| 6-mo | 36.43% |
| 1-year | -2.22% |
| 3-year | 95.01% |
| 5-year | -29.88% |
| YTD | -1.12% |
| 2023 | 29.93% |
| 2022 | 64.72% |
| 2021 | -77.09% |
| 2020 | 10.67% |
| 2019 | 5.47% |
Continue Researching PLX
Want to see what other sources are saying about Protalix BioTherapeutics Inc's financials and stock price? Try the links below:Protalix BioTherapeutics Inc (PLX) Stock Price | Nasdaq
Protalix BioTherapeutics Inc (PLX) Stock Quote, History and News - Yahoo Finance
Protalix BioTherapeutics Inc (PLX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...